Berko Pharmaceuticals was entitled to receive the "COVID-19 Safe Manufacturing Site Certificate" issued by the Turkish Standards Institution (TSE) thanks to the measures taken and practices implemented in its factory, field and head office from the very beginning of the COVID-19 process.
Berko Pharmaceuticals, which has been working and producing for public health with the vision of "For Healthy Tomorrows" for more than thirty-five years, has been entitled to receive the "COVID-19 Safe Manufacturing Facility Certificate" issued by the Turkish Standards Institution (TSE) with the measures it has taken in its production and working areas, the high-level hygiene measures it has implemented for its employees and the practices it has implemented for all its stakeholders since the COVID-19 pandemic, which has affected the whole world, started to be seen in our country.
Making a statement on the subject, Berko Pharmaceuticals General Manager Pharm. Barış Özyurtlu stated that "They have successfully passed the audits of the Turkish Standards Institution and were entitled to receive the 'Safe Manufacturing Facility Certificate' and that hygiene and safety are always at the highest levels in their Manufacturing Facility, not only during the COVID-19 process, but also in accordance with GMP (Good Manufacturing Practice) standards". Özyurtlu’s stated that they are proud to prove once again the sensitivity they have shown to public health in order to reach For Healthy Tomorrows within the framework of the mission that Berko Pharmaceuticals has imposed on itself.